- Home
- KRYS vs LMND Comparison
KRYS vs LMND Comparison
Compare KRYS & LMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- LMND
- Stock Information
- Founded
- KRYS 2015
- LMND 2015
- Country
- KRYS United States
- LMND United States
- Employees
- KRYS N/A
- LMND N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- LMND Property-Casualty Insurers
- Sector
- KRYS Health Care
- LMND Finance
- Exchange
- KRYS Nasdaq
- LMND Nasdaq
- Market Cap
- KRYS 4.7B
- LMND 3.9B
- IPO Year
- KRYS 2017
- LMND 2020
- Fundamental
- Price
- KRYS $196.65
- LMND $74.95
- Analyst Decision
- KRYS Strong Buy
- LMND Hold
- Analyst Count
- KRYS 9
- LMND 10
- Target Price
- KRYS $214.22
- LMND $40.10
- AVG Volume (30 Days)
- KRYS 316.5K
- LMND 3.1M
- Earning Date
- KRYS 11-03-2025
- LMND 11-05-2025
- Dividend Yield
- KRYS N/A
- LMND N/A
- EPS Growth
- KRYS 275.72
- LMND N/A
- EPS
- KRYS 6.66
- LMND N/A
- Revenue
- KRYS $373,164,000.00
- LMND $658,300,000.00
- Revenue This Year
- KRYS $34.33
- LMND $38.27
- Revenue Next Year
- KRYS $48.04
- LMND $63.05
- P/E Ratio
- KRYS $29.71
- LMND N/A
- Revenue Growth
- KRYS 54.51
- LMND 33.66
- 52 Week Low
- KRYS $122.80
- LMND $24.31
- 52 Week High
- KRYS $212.98
- LMND $81.90
- Technical
- Relative Strength Index (RSI)
- KRYS 59.19
- LMND 68.75
- Support Level
- KRYS $194.92
- LMND $58.26
- Resistance Level
- KRYS $212.98
- LMND $81.90
- Average True Range (ATR)
- KRYS 8.35
- LMND 4.61
- MACD
- KRYS -0.17
- LMND 2.41
- Stochastic Oscillator
- KRYS 42.14
- LMND 78.34
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About LMND Lemonade Inc.
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.